Abstract
Understanding the etiologies underlying congenital limb anomalies is an important step in developing corrective or preventative therapies. To accomplish this task, knowledge of how the limb develops is crucial. The position of limb outgrowth is under precise molecular control. In addition, the subsequent growth and differentiation of the limb are tightly regulated by a complex network of signaling molecules secreted by specialized zones in the limb, known as signaling centers. Any disruption in the regulation of these molecules can cause dysmorphogenesis or dysplasias that result in congenital limb anomalies. This chapter will review recent insights from developmental biology, clinical genetics, and hand surgery that define our current understanding of how limb anomalies occur.
Author supplied keywords
- AER
- Angiogenesis
- Animal models
- Apical ectodermal ridge
- Bmp4
- Bone morphogenetic protein family member 4
- Classification
- Congenital upper limb malformation
- Dorsal ectoderm
- Embryology
- Fgf8
- Fibroblast growth factor 8
- Genetic mutation
- Homeobox genes
- Hox
- Human
- Innervation
- Lim homeobox 1b
- Limb development
- Lmx1b
- Molecular regulation
- Morphogenesis
- Myogenesis
- Patterning
- RA
- Retinoic acid
- Shh
- Skeletogenesis
- Sonic hedgehog
- Tissue differentiation
- Vasculogenesis
- Wingless-type MMTV integration site family member 7A
- Wnt7a
- ZPA
- Zone of polarizing activity
Cite
CITATION STYLE
Ball, K. F., Tonkin, M. A., & Oberg, K. C. (2021). Embryology and classification of congenital upper limb anomalies. In Congenital Anomalies of the Upper Extremity: Etiology and Management (pp. 3–35). Springer International Publishing. https://doi.org/10.1007/978-3-030-64159-7_1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.